Publications by authors named "Samuel Augustine"

Claim this Profile
A
Assessing the stability of common radiopharmaceuticals compounded and utilized outside package insert guidelines.
Kara D Weatherman, Samuel Augustine, Jeffrey Christoff, Wendy Galbraith

Int J Pharm Compd· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing benchmark rates of microbial and bacterial endotoxin contamination for radiopharmaceuticals compounded in commercial nuclear pharmacy settings.
Kara D Weatherman, Samuel Augustine, Jeffrey Christoff, Wendy Galbraith

Int J Pharm Compd· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication therapy management training using case studies and the MirixaPro platform.
Kimberley J Begley, Kelli L Coover, Jennifer A Tilleman, Ann M Ryan Haddad, Samuel C Augustine

Am J Pharm Educ· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination and control of volatilized 131I released in the preparation of 131I tositumomab dosages for radioimmunotherapy.
Samuel C Augustine, David M Colcher, Frank J Rutar, Jeffrey P Norenberg, Kao Vang

J Am Pharm Assoc (2003)· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab.
Maribeth A Hohenstein, Samuel C Augustine, Frank Rutar, Julie M Vose

Semin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
Joseph C Hung, Samuel C Augustine, Kenneth T Cheng, Richard L Green, Wade M Hopkins

J Am Pharm Assoc (Wash)· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.
Samuel C Augustine, Jeffrey P Norenberg, David M Colcher, Julie M Vose, Lisa S Gobar

J Am Pharm Assoc (Wash)· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis